HEADER HYDROLASE 05-DEC-00 1HFJ TITLE ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH SULFATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: L-ASPARAGINE AMIDOHYDROLASE; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: L-ASPARAGINASE, L-ASNASE; COMPND 5 EC: 3.5.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ERWINIA CHRYSANTHEMI; SOURCE 3 ORGANISM_TAXID: 556; SOURCE 4 STRAIN: NCPPB 1125; SOURCE 5 OTHER_DETAILS: THE NEW NAME OF ERWINIA CHRYSANTHEMI IS SOURCE 6 PECTOBACTERIUM CHRYSANTHEMI. KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.J.PALM,J.LUBKOWSKI,M.KOZAK,M.JASKOLSKI,A.WLODAWER REVDAT 5 08-MAY-19 1HFJ 1 REMARK REVDAT 4 19-OCT-11 1HFJ 1 HEADER KEYWDS JRNL REMARK REVDAT 4 2 1 FORMUL VERSN REVDAT 3 24-FEB-09 1HFJ 1 VERSN REVDAT 2 05-MAR-01 1HFJ 1 JRNL REVDAT 1 07-DEC-00 1HFJ 0 JRNL AUTH M.JASKOLSKI,M.KOZAK,J.LUBKOWSKI,G.J.PALM,A.WLODAWER JRNL TITL STRUCTURES OF TWO HIGHLY HOMOLOGOUS BACTERIAL JRNL TITL 2 L-ASPARAGINASES: A CASE OF ENANTIOMORPHIC SPACE GROUPS JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 57 369 2001 JRNL REFN ISSN 0907-4449 JRNL PMID 11223513 JRNL DOI 10.1107/S0907444900020175 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.L.SWAIN,M.JASKOLSKI,D.HOUSSET,J.K.M.RAO,A.WLODAWER REMARK 1 TITL CRYSTAL STRUCTURE OF ESCHERICHIA COLI L-ASPARAGINASE, AN REMARK 1 TITL 2 ENZYME USED IN CANCER THERAPY REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 1474 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 8434007 REMARK 1 DOI 10.1073/PNAS.90.4.1474 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.MILLER,J.K.M.RAO,A.WLODAWER,M.R.GRIBSKOV REMARK 1 TITL A LEFT-HANDED CROSSOVER INVOLVED IN AMIDOHYDROLASE REMARK 1 TITL 2 CATALYSIS, CRYSTAL STRUCTURE OF ERWINIA CHRYSANTHEMI REMARK 1 TITL 3 L-ASPARAGINASE WITH BOUND L-ASPARTATE REMARK 1 REF FEBS LETT. V. 328 275 1993 REMARK 1 REFN ISSN 0014-5793 REMARK 1 PMID 8348975 REMARK 1 DOI 10.1016/0014-5793(93)80943-O REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF (MAXIMUM LIKELYHOOD ON F'S) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.9 REMARK 3 NUMBER OF REFLECTIONS : 27603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1371 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 27 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 622 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4904 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 515 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.42900 REMARK 3 B22 (A**2) : -0.42900 REMARK 3 B33 (A**2) : 0.85800 REMARK 3 B12 (A**2) : -1.91200 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 10.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.420 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.850 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.000 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 0.000 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 0.000 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 0.000 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 46.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : 0 ; 0 REMARK 3 GROUP 1 B-FACTOR (A**2) : 0 ; 0 REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HFJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1290005587. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-95 REMARK 200 TEMPERATURE (KELVIN) : 293.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER, 0.00025MM REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : R-AXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29191 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.3 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10500 REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28000 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.0, X-PLOR 3.1 REMARK 200 STARTING MODEL: FROM REFERENCE 3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.97 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP. PROTEIN SOLUTION: 35 REMARK 280 MG/ML PROTEIN, 0.1 M CHES PH 8.5. WELL SOLUTION: 47% AMMONIUM REMARK 280 SULFATE, 2% PEG 400, PH 8.50, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 115.53333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 231.06667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 173.30000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 288.83333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 57.76667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 115.53333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 231.06667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 288.83333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 173.30000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 57.76667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: IN THE TETRAMER TWO ACTIVE SITES ARE REMARK 300 FORMED BY EACH INTIMATE DIMER AC AND ITS REMARK 300 CRYSTALLOGRAPHIC SYMMETRY MATE REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 18380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -117.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 0.866025 0.000000 -45.70000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 79.15472 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 57.76667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ASP A 2 REMARK 465 ALA C 1 REMARK 465 ASP C 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 221 OH TYR C 232 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 58 -176.24 -171.11 REMARK 500 ASN A 59 79.13 -158.35 REMARK 500 SER A 172 35.05 -156.43 REMARK 500 ASP A 200 51.22 -94.97 REMARK 500 THR A 204 -107.38 35.25 REMARK 500 SER A 276 -160.24 -120.10 REMARK 500 ASP A 296 -132.60 59.75 REMARK 500 ARG A 313 -44.60 -133.10 REMARK 500 SER C 58 -175.85 -170.12 REMARK 500 ASN C 59 82.74 -157.41 REMARK 500 SER C 172 31.22 -154.77 REMARK 500 ASP C 200 51.46 -94.66 REMARK 500 THR C 204 -108.87 35.44 REMARK 500 SER C 276 -160.53 -122.24 REMARK 500 ASP C 296 -134.15 58.33 REMARK 500 ARG C 313 -39.85 -131.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2034 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH C2008 DISTANCE = 7.15 ANGSTROMS REMARK 525 HOH C2110 DISTANCE = 5.86 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 400 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3PGA RELATED DB: PDB REMARK 900 GLUTAMINASE-ASPARAGINASE (E.C.3.5.1.1) (AMIDOHYDROLASE, REMARK 900 ASPARAGINASE FROM PSEUDOMONAS 7A REMARK 900 RELATED ID: 1HFK RELATED DB: PDB REMARK 900 ASPARAGINASE FROM ERWINIA CHRYSANTHEMI, HEXAGONAL FORM WITH PARTIAL REMARK 900 SULFATE REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 1 TO 21 IN THE DATABASE ENTRY REMARK 999 CONSTITUTE THE LEADER PEPTIDE. DBREF 1HFJ A 1 327 UNP P06608 ASPG_ERWCH 22 348 DBREF 1HFJ C 1 327 UNP P06608 ASPG_ERWCH 22 348 SEQADV 1HFJ ILE A 156 UNP P06608 LEU 177 VARIANT SEQADV 1HFJ ARG A 178 UNP P06608 LYS 199 VARIANT SEQADV 1HFJ LEU A 267 UNP P06608 MET 288 VARIANT SEQADV 1HFJ MET A 274 UNP P06608 ILE 295 VARIANT SEQADV 1HFJ ILE C 156 UNP P06608 LEU 177 VARIANT SEQADV 1HFJ ARG C 178 UNP P06608 LYS 199 VARIANT SEQADV 1HFJ LEU C 267 UNP P06608 MET 288 VARIANT SEQADV 1HFJ MET C 274 UNP P06608 ILE 295 VARIANT SEQRES 1 A 327 ALA ASP LYS LEU PRO ASN ILE VAL ILE LEU ALA THR GLY SEQRES 2 A 327 GLY THR ILE ALA GLY SER ALA ALA THR GLY THR GLN THR SEQRES 3 A 327 THR GLY TYR LYS ALA GLY ALA LEU GLY VAL ASP THR LEU SEQRES 4 A 327 ILE ASN ALA VAL PRO GLU VAL LYS LYS LEU ALA ASN VAL SEQRES 5 A 327 LYS GLY GLU GLN PHE SER ASN MET ALA SER GLU ASN MET SEQRES 6 A 327 THR GLY ASP VAL VAL LEU LYS LEU SER GLN ARG VAL ASN SEQRES 7 A 327 GLU LEU LEU ALA ARG ASP ASP VAL ASP GLY VAL VAL ILE SEQRES 8 A 327 THR HIS GLY THR ASP THR VAL GLU GLU SER ALA TYR PHE SEQRES 9 A 327 LEU HIS LEU THR VAL LYS SER ASP LYS PRO VAL VAL PHE SEQRES 10 A 327 VAL ALA ALA MET ARG PRO ALA THR ALA ILE SER ALA ASP SEQRES 11 A 327 GLY PRO MET ASN LEU LEU GLU ALA VAL ARG VAL ALA GLY SEQRES 12 A 327 ASP LYS GLN SER ARG GLY ARG GLY VAL MET VAL VAL ILE SEQRES 13 A 327 ASN ASP ARG ILE GLY SER ALA ARG TYR ILE THR LYS THR SEQRES 14 A 327 ASN ALA SER THR LEU ASP THR PHE ARG ALA ASN GLU GLU SEQRES 15 A 327 GLY TYR LEU GLY VAL ILE ILE GLY ASN ARG ILE TYR TYR SEQRES 16 A 327 GLN ASN ARG ILE ASP LYS LEU HIS THR THR ARG SER VAL SEQRES 17 A 327 PHE ASP VAL ARG GLY LEU THR SER LEU PRO LYS VAL ASP SEQRES 18 A 327 ILE LEU TYR GLY TYR GLN ASP ASP PRO GLU TYR LEU TYR SEQRES 19 A 327 ASP ALA ALA ILE GLN HIS GLY VAL LYS GLY ILE VAL TYR SEQRES 20 A 327 ALA GLY MET GLY ALA GLY SER VAL SER VAL ARG GLY ILE SEQRES 21 A 327 ALA GLY MET ARG LYS ALA LEU GLU LYS GLY VAL VAL VAL SEQRES 22 A 327 MET ARG SER THR ARG THR GLY ASN GLY ILE VAL PRO PRO SEQRES 23 A 327 ASP GLU GLU LEU PRO GLY LEU VAL SER ASP SER LEU ASN SEQRES 24 A 327 PRO ALA HIS ALA ARG ILE LEU LEU MET LEU ALA LEU THR SEQRES 25 A 327 ARG THR SER ASP PRO LYS VAL ILE GLN GLU TYR PHE HIS SEQRES 26 A 327 THR TYR SEQRES 1 C 327 ALA ASP LYS LEU PRO ASN ILE VAL ILE LEU ALA THR GLY SEQRES 2 C 327 GLY THR ILE ALA GLY SER ALA ALA THR GLY THR GLN THR SEQRES 3 C 327 THR GLY TYR LYS ALA GLY ALA LEU GLY VAL ASP THR LEU SEQRES 4 C 327 ILE ASN ALA VAL PRO GLU VAL LYS LYS LEU ALA ASN VAL SEQRES 5 C 327 LYS GLY GLU GLN PHE SER ASN MET ALA SER GLU ASN MET SEQRES 6 C 327 THR GLY ASP VAL VAL LEU LYS LEU SER GLN ARG VAL ASN SEQRES 7 C 327 GLU LEU LEU ALA ARG ASP ASP VAL ASP GLY VAL VAL ILE SEQRES 8 C 327 THR HIS GLY THR ASP THR VAL GLU GLU SER ALA TYR PHE SEQRES 9 C 327 LEU HIS LEU THR VAL LYS SER ASP LYS PRO VAL VAL PHE SEQRES 10 C 327 VAL ALA ALA MET ARG PRO ALA THR ALA ILE SER ALA ASP SEQRES 11 C 327 GLY PRO MET ASN LEU LEU GLU ALA VAL ARG VAL ALA GLY SEQRES 12 C 327 ASP LYS GLN SER ARG GLY ARG GLY VAL MET VAL VAL ILE SEQRES 13 C 327 ASN ASP ARG ILE GLY SER ALA ARG TYR ILE THR LYS THR SEQRES 14 C 327 ASN ALA SER THR LEU ASP THR PHE ARG ALA ASN GLU GLU SEQRES 15 C 327 GLY TYR LEU GLY VAL ILE ILE GLY ASN ARG ILE TYR TYR SEQRES 16 C 327 GLN ASN ARG ILE ASP LYS LEU HIS THR THR ARG SER VAL SEQRES 17 C 327 PHE ASP VAL ARG GLY LEU THR SER LEU PRO LYS VAL ASP SEQRES 18 C 327 ILE LEU TYR GLY TYR GLN ASP ASP PRO GLU TYR LEU TYR SEQRES 19 C 327 ASP ALA ALA ILE GLN HIS GLY VAL LYS GLY ILE VAL TYR SEQRES 20 C 327 ALA GLY MET GLY ALA GLY SER VAL SER VAL ARG GLY ILE SEQRES 21 C 327 ALA GLY MET ARG LYS ALA LEU GLU LYS GLY VAL VAL VAL SEQRES 22 C 327 MET ARG SER THR ARG THR GLY ASN GLY ILE VAL PRO PRO SEQRES 23 C 327 ASP GLU GLU LEU PRO GLY LEU VAL SER ASP SER LEU ASN SEQRES 24 C 327 PRO ALA HIS ALA ARG ILE LEU LEU MET LEU ALA LEU THR SEQRES 25 C 327 ARG THR SER ASP PRO LYS VAL ILE GLN GLU TYR PHE HIS SEQRES 26 C 327 THR TYR HET SO4 A 400 5 HET SO4 C 400 5 HETNAM SO4 SULFATE ION FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *515(H2 O) HELIX 1 1 THR A 15 GLY A 18 5 4 HELIX 2 2 GLY A 35 VAL A 43 1 9 HELIX 3 3 PRO A 44 LEU A 49 5 6 HELIX 4 4 ALA A 61 MET A 65 5 5 HELIX 5 5 THR A 66 ARG A 83 1 18 HELIX 6 6 THR A 97 VAL A 109 1 13 HELIX 7 7 ASP A 130 ASP A 144 1 15 HELIX 8 8 LYS A 145 ARG A 148 5 4 HELIX 9 9 HIS A 203 SER A 207 5 5 HELIX 10 10 GLU A 231 GLN A 239 1 9 HELIX 11 11 SER A 256 GLU A 268 1 13 HELIX 12 12 ASN A 299 LEU A 311 1 13 HELIX 13 13 ASP A 316 TYR A 327 1 12 HELIX 14 14 THR C 15 GLY C 18 5 4 HELIX 15 15 GLY C 35 VAL C 43 1 9 HELIX 16 16 PRO C 44 LEU C 49 5 6 HELIX 17 17 ALA C 61 MET C 65 5 5 HELIX 18 18 THR C 66 ARG C 83 1 18 HELIX 19 19 THR C 97 VAL C 109 1 13 HELIX 20 20 ASP C 130 ASP C 144 1 15 HELIX 21 21 LYS C 145 ARG C 148 5 4 HELIX 22 22 HIS C 203 SER C 207 5 5 HELIX 23 23 GLU C 231 GLN C 239 1 9 HELIX 24 24 SER C 256 GLU C 268 1 13 HELIX 25 25 ASN C 299 LEU C 311 1 13 HELIX 26 26 ASP C 316 TYR C 327 1 12 SHEET 1 AA 8 ASN A 51 MET A 60 0 SHEET 2 AA 8 ASN A 6 GLY A 13 1 O ILE A 7 N LYS A 53 SHEET 3 AA 8 GLY A 88 THR A 92 1 O GLY A 88 N VAL A 8 SHEET 4 AA 8 VAL A 115 VAL A 118 1 O VAL A 116 N ILE A 91 SHEET 5 AA 8 MET A 153 ILE A 156 1 O MET A 153 N PHE A 117 SHEET 6 AA 8 ARG A 159 SER A 162 -1 O ARG A 159 N ILE A 156 SHEET 7 AA 8 GLY A 186 ILE A 189 -1 O GLY A 186 N ILE A 160 SHEET 8 AA 8 ARG A 192 TYR A 195 -1 O ARG A 192 N ILE A 189 SHEET 1 AB 2 THR A 167 LYS A 168 0 SHEET 2 AB 2 PHE A 177 ARG A 178 -1 O ARG A 178 N THR A 167 SHEET 1 AC 4 VAL A 220 TYR A 224 0 SHEET 2 AC 4 GLY A 244 GLY A 249 1 O GLY A 244 N ASP A 221 SHEET 3 AC 4 VAL A 272 THR A 277 1 O VAL A 272 N ILE A 245 SHEET 4 AC 4 LEU A 293 VAL A 294 1 O LEU A 293 N ARG A 275 SHEET 1 CA 8 ASN C 51 MET C 60 0 SHEET 2 CA 8 ASN C 6 GLY C 13 1 O ILE C 7 N LYS C 53 SHEET 3 CA 8 GLY C 88 THR C 92 1 O GLY C 88 N VAL C 8 SHEET 4 CA 8 VAL C 115 VAL C 118 1 O VAL C 116 N ILE C 91 SHEET 5 CA 8 MET C 153 ILE C 156 1 O MET C 153 N PHE C 117 SHEET 6 CA 8 ARG C 159 SER C 162 -1 O ARG C 159 N ILE C 156 SHEET 7 CA 8 GLY C 186 ILE C 189 -1 O GLY C 186 N ILE C 160 SHEET 8 CA 8 ARG C 192 TYR C 195 -1 O ARG C 192 N ILE C 189 SHEET 1 CB 2 THR C 167 LYS C 168 0 SHEET 2 CB 2 PHE C 177 ARG C 178 -1 O ARG C 178 N THR C 167 SHEET 1 CC 4 VAL C 220 TYR C 224 0 SHEET 2 CC 4 GLY C 244 GLY C 249 1 O GLY C 244 N ASP C 221 SHEET 3 CC 4 VAL C 272 THR C 277 1 O VAL C 272 N ILE C 245 SHEET 4 CC 4 LEU C 293 VAL C 294 1 O LEU C 293 N ARG C 275 SITE 1 AC1 8 GLY A 14 THR A 15 ALA A 61 SER A 62 SITE 2 AC1 8 GLY A 94 THR A 95 ASP A 96 HOH A2237 SITE 1 AC2 8 GLY C 14 THR C 15 ALA C 61 SER C 62 SITE 2 AC2 8 GLY C 94 THR C 95 ASP C 96 HOH C2053 CRYST1 91.400 91.400 346.600 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010941 0.006317 0.000000 0.00000 SCALE2 0.000000 0.012633 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002885 0.00000 MTRIX1 1 -0.992362 -0.013099 -0.122660 -5.99338 1 MTRIX2 1 -0.012850 -0.977960 0.208396 92.47156 1 MTRIX3 1 -0.122686 0.208381 0.970322 -10.14424 1